.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Chris Garabedian
Chris GarabedianFORGE BIOLOGICS

Chris Garabedian

Chairman of Board of Director at FORGE BIOLOGICS

Manager

Deal Bio

Total Deals2
Valued Deals1
Total Value£429M
Avg. Deal Size£429M

Expertise (2)

Key Relationships

United States
Biotechnology
DomesticMajorityPrivateAcquisitionReverse TakeoverMerger
Quellis Biosciences

target

Quellis Biosciences

Catabasis Pharmaceuticals

bidder

Catabasis Pharmaceuticals

value n/a

23 dealmakers

United States
Biotechnology
AcquisitionMajorityPrivateCross Border
Forge Biologics

target

Forge Biologics

Ajinomoto Co

bidder

Ajinomoto Co

£429m

9 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US